Digitisation | August 04, 2022
Creoptix launches new WAVEcontrol to deliver automated and label-free analysis for biologics drug-discovery
The WAVEsystem with the WAVEcontrol 4.0 embedded
The WAVEsystem with the WAVEcontrol 4.0 embedded
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Upon closing, the Quakertown business will become an independent company called Microsize
The facility is among 12 centres established worldwide, and the first in Asia
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
Subscribe To Our Newsletter & Stay Updated
